Evaluation of serum mesothelin in malignant and benign ovarian masses.
about
Correlation Between Tumor Mesothelin Expression and Serum Mesothelin in Patients with Epithelial Ovarian Carcinoma: A Potential Noninvasive Biomarker for Mesothelin-targeted Therapy.Biological markers of prognosis, response to therapy and outcome in ovarian carcinoma.Improving cancer detection through combinations of cancer and immune biomarkers: a modelling approach.
P2860
Evaluation of serum mesothelin in malignant and benign ovarian masses.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
Evaluation of serum mesothelin in malignant and benign ovarian masses.
@en
Evaluation of serum mesothelin in malignant and benign ovarian masses.
@nl
type
label
Evaluation of serum mesothelin in malignant and benign ovarian masses.
@en
Evaluation of serum mesothelin in malignant and benign ovarian masses.
@nl
prefLabel
Evaluation of serum mesothelin in malignant and benign ovarian masses.
@en
Evaluation of serum mesothelin in malignant and benign ovarian masses.
@nl
P2093
P2860
P1476
Evaluation of serum mesothelin in malignant and benign ovarian masses.
@en
P2093
Ahmed Bahaa
Ahmed Ibrahim
Amira Abd El Hakem
Ayman Abo-El Noor
Moustafa Ibrahim
Usama El Tohamy
P2860
P2888
P304
P356
10.1007/S00404-014-3147-2
P577
2014-01-21T00:00:00Z